Vascular endothelial growth factor and angiogenesis ANN Hoeben, B Landuyt, MS Highley, H Wildiers, AT Van Oosterom, ... Pharmacological reviews 56 (4), 549-580, 2004 | 2595 | 2004 |
International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer H Wildiers, P Heeren, M Puts, E Topinkova, MLG Janssen-Heijnen, ... Journal of clinical oncology 32 (24), 2595, 2014 | 1654 | 2014 |
Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017 | 1325 | 2017 |
Polygenic risk scores for prediction of breast cancer and breast cancer subtypes N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ... The American Journal of Human Genetics 104 (1), 21-34, 2019 | 909 | 2019 |
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies XR Yang, J Chang-Claude, EL Goode, FJ Couch, H Nevanlinna, RL Milne, ... Journal of the National Cancer Institute 103 (3), 250-263, 2011 | 840 | 2011 |
Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial IE Krop, SB Kim, A González-Martín, PM LoRusso, JM Ferrero, M Smitt, ... The Lancet Oncology 15 (7), 689-699, 2014 | 772 | 2014 |
Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations L Decoster, K Van Puyvelde, S Mohile, U Wedding, U Basso, G Colloca, ... Annals of Oncology 26 (2), 288-300, 2015 | 764 | 2015 |
Prediction of breast cancer risk based on profiling with common genetic variants N Mavaddat, PDP Pharoah, K Michailidou, J Tyrer, MN Brook, MK Bolla, ... Journal of the National Cancer Institute 107 (5), djv036, 2015 | 672 | 2015 |
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer K Michailidou, J Beesley, S Lindstrom, S Canisius, J Dennis, MJ Lush, ... Nature genetics 47 (4), 373-380, 2015 | 652 | 2015 |
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 647 | 2013 |
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer MN Dickler, SM Tolaney, HS Rugo, J Cortés, V Diéras, D Patt, H Wildiers, ... Clinical Cancer Research 23 (17), 5218-5224, 2017 | 637 | 2017 |
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer … L Biganzoli, H Wildiers, C Oakman, L Marotti, S Loibl, I Kunkler, M Reed, ... The lancet oncology 13 (4), e148-e160, 2012 | 635 | 2012 |
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival … IE Krop, SB Kim, AG Martin, PM LoRusso, JM Ferrero, ... The Lancet Oncology 18 (6), 743-754, 2017 | 489 | 2017 |
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help A SIOG surgical task force prospective study RA Audisio Critical Reviews in Oncology and Hematology, 2008 | 463 | 2008 |
Neratinib plus capecitabine versus lapatinib plus capecitabine in HER2-positive metastatic breast cancer previously treated with≥ 2 HER2-directed regimens: phase III NALA trial C Saura, M Oliveira, YH Feng, MS Dai, SW Chen, SA Hurvitz, SB Kim, ... Journal of Clinical Oncology 38 (27), 3138, 2020 | 453 | 2020 |
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open … SA Hurvitz, M Martin, WF Symmans, KH Jung, CS Huang, AM Thompson, ... The Lancet Oncology 19 (1), 115-126, 2018 | 451 | 2018 |
Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology H Wildiers, I Kunkler, L Biganzoli, J Fracheboud, G Vlastos, ... The lancet oncology 8 (12), 1101-1115, 2007 | 423 | 2007 |
Performance of two geriatric screening tools in older patients with cancer C Kenis, L Decoster, K Van Puyvelde, J De Grève, G Conings, K Milisen, ... J Clin Oncol 32 (1), 19-26, 2014 | 387 | 2014 |
Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study F Amant, G von Minckwitz, SN Han, M Bontenbal, AE Ring, J Giermek, ... Journal of Clinical Oncology 31 (20), 2532-2539, 2013 | 383 | 2013 |
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer A Bassez, H Vos, L Van Dyck, G Floris, I Arijs, C Desmedt, B Boeckx, ... Nature medicine 27 (5), 820-832, 2021 | 382 | 2021 |